CCM
JNCE

CAAS Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

CAAS Capital Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,052,437
Closed -$10.8M – 1065
2021
Q1 		$10.8M Buy
+1,052,437
New +$10.8M 0.12% 80